Demographics of Positional Plagiocephaly and Brachycephaly; Risk Factors and Treatment

2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Cas van Cruchten ◽  
Michelle Marlena Wilhelmina Feijen ◽  
Rene Remmelt Willie Johan van der Hulst
2014 ◽  
Vol 19 (8) ◽  
pp. 423-427 ◽  
Author(s):  
Aliyah Mawji ◽  
Ardene Robinson Vollman ◽  
Tak Fung ◽  
Jennifer Hatfield ◽  
Deborah A McNeil ◽  
...  

2021 ◽  
Vol 4 (1) ◽  
pp. 33-33
Author(s):  
Esmaeil Chahaki ◽  
◽  
Mohamadali Javanshir ◽  
Hassan Saeeidi ◽  
Mohamdmahdi Taghdiri ◽  
...  

Background and Objectives: Positional plagiocephaly is one of the most common skull deformities that ultimately lead to the asymmetry of the head and face in different ranges. This study aimed to estimate the prevalence of plagiocephaly and analyze the relationship between risk factors and the severity level of the deformities in children referred to the Mofid hospital. Methods: In a cross-sectional study, the cranial vault asymmetry index was calculated from a routine head scan with a noninvasive laser shape digitizer. Data were recorded and categorized by the type and severity of deformation. Also, for the analysis of risk factors, data about sitting, feeding, and sleeping positions were gathered from parents. Results: The study participants included 90 children, and the prevalence of head deformity was 35% (32 infants) with mild to moderate severity. According to the risk factors, infant positions are significantly correlated with the severity of plagiocephaly. Conclusion: Parents’ awareness of changing the head position plays an important role to reduce the risk of plagiocephaly in children.


2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Safak Uygur ◽  
Nicholas O'Sick ◽  
Petros Konofaos

Author(s):  
Erin R Wallace ◽  
Cindy Ola ◽  
Brian G Leroux ◽  
Matthew L Speltz ◽  
Brent R Collett

Abstract Introduction Children with positional plagiocephaly and/or brachycephaly (PPB) are at risk of early developmental delay, but little is known about early life factors associated with school-age neurodevelopment. This study examined associations of demographic characteristics, prenatal risk factors and early neurodevelopment assessment with school-age IQ, academic performance, and motor development in children with PPB. Methods The study sample consisted of 235 school-age children with PPB followed since infancy. Outcome measures included IQ using the Differential Ability Scales-Second Edition, academic achievement as measured by the Wechsler Individualized Achievement Tests-Third Edition), and motor function using the Bruininks-Oseretsky Test of Motor Proficiency, Second Edition. Linear regression was used to examine the incremental improvement of model fit of demographics, prenatal and early life characteristics, severity of PPB, and neurodevelopment at ages 7, 18, and 36 months as measured by the Bayley-3 on school-age scores. Results Mean age at school-age assessment was 9.0 years. Adjusted r2 for demographic, prenatal, and early life risk factors ranged from 0.10 to 0.22. Addition of PPB severity and Bayley-3 measures at ages 7 and 18 months did not meaningfully change model fit. Adjusted r2 after inclusion of Bayley-3 at 36 months ranged from 0.35 to 0.41. Conclusion This study suggests that PPB severity and very early life neurodevelopment have little association with school-age neurodevelopment above and beyond demographic and early life risk factors. However, preschool-age neurodevelopmental assessment may still be useful in identifying children with PPB at risk for delay and who may benefit from early intervention.


2019 ◽  
Vol 133 (22) ◽  
pp. 2283-2299
Author(s):  
Apabrita Ayan Das ◽  
Devasmita Chakravarty ◽  
Debmalya Bhunia ◽  
Surajit Ghosh ◽  
Prakash C. Mandal ◽  
...  

Abstract The role of inflammation in all phases of atherosclerotic process is well established and soluble TREM-like transcript 1 (sTLT1) is reported to be associated with chronic inflammation. Yet, no information is available about the involvement of sTLT1 in atherosclerotic cardiovascular disease. Present study was undertaken to determine the pathophysiological significance of sTLT1 in atherosclerosis by employing an observational study on human subjects (n=117) followed by experiments in human macrophages and atherosclerotic apolipoprotein E (apoE)−/− mice. Plasma level of sTLT1 was found to be significantly (P<0.05) higher in clinical (2342 ± 184 pg/ml) and subclinical cases (1773 ± 118 pg/ml) than healthy controls (461 ± 57 pg/ml). Moreover, statistical analyses further indicated that sTLT1 was not only associated with common risk factors for Coronary Artery Disease (CAD) in both clinical and subclinical groups but also strongly correlated with disease severity. Ex vivo studies on macrophages showed that sTLT1 interacts with Fcɣ receptor I (FcɣRI) to activate spleen tyrosine kinase (SYK)-mediated downstream MAP kinase signalling cascade to activate nuclear factor-κ B (NF-kB). Activation of NF-kB induces secretion of tumour necrosis factor-α (TNF-α) from macrophage cells that plays pivotal role in governing the persistence of chronic inflammation. Atherosclerotic apoE−/− mice also showed high levels of sTLT1 and TNF-α in nearly occluded aortic stage indicating the contribution of sTLT1 in inflammation. Our results clearly demonstrate that sTLT1 is clinically related to the risk factors of CAD. We also showed that binding of sTLT1 with macrophage membrane receptor, FcɣR1 initiates inflammatory signals in macrophages suggesting its critical role in thrombus development and atherosclerosis.


2011 ◽  
Vol 21 (2) ◽  
pp. 59-62
Author(s):  
Joseph Donaher ◽  
Christina Deery ◽  
Sarah Vogel

Healthcare professionals require a thorough understanding of stuttering since they frequently play an important role in the identification and differential diagnosis of stuttering for preschool children. This paper introduces The Preschool Stuttering Screen for Healthcare Professionals (PSSHP) which highlights risk factors identified in the literature as being associated with persistent stuttering. By integrating the results of the checklist with a child’s developmental profile, healthcare professionals can make better-informed, evidence-based decisions for their patients.


2010 ◽  
Vol 20 (3) ◽  
pp. 76-83 ◽  
Author(s):  
Joseph Donaher ◽  
Tom Gurrister ◽  
Irving Wollman ◽  
Tim Mackesey ◽  
Michelle L. Burnett

Parents of children who stutter and adults who stutter frequently ask speech-language pathologists to predict whether or not therapy will work. Even though research has explored risk-factors related to persistent stuttering, there remains no way to determine how an individual will react to a specific therapy program. This paper presents various clinicians’answers to the question, “What do you tell parents or adults who stutter when they ask about cure rates, outcomes, and therapy efficacy?”


Sign in / Sign up

Export Citation Format

Share Document